Vor Biopharma Inc. 4

David Zaccardelli received a stock option award for 42,658 shares of Vor Biopharma Inc. common stock at a $20.10 exercise price.

On July 7, 2026, David Zaccardelli received an option grant from Vor Biopharma Inc. covering 42,658 shares of common stock at an exercise price of $20.10 per share. This award is a compensatory stock option that will vest in 36 equal monthly installments beginning August 7, 2026, contingent on his continued service, and if fully vested and exercised would represent an aggregate purchase opportunity of approximately $857,426. After this grant, his derivative ownership position increased by the full 42,658-option amount, while his corresponding underlying common stock equivalent holdings rose by the same notional share count.

Filing Facts

CIK

1817229

Ticker

VOR

Form

4

Source Type

fda

Accession

0001193125-26-299665

Alert Tier

6